These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1671136)

  • 21. [Long-term effects of inhaled beta 2-agonists on bronchial hyperresponsiveness in asthmatics].
    Ogawa C; Sano Y
    Nihon Rinsho; 1996 Nov; 54(11):3081-6. PubMed ID: 8950959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma.
    Lipworth BJ; Jackson C
    Am J Respir Crit Care Med; 1999 Dec; 160(6):2125-6. PubMed ID: 10755831
    [No Abstract]   [Full Text] [Related]  

  • 23. Nebulized beta 2-adrenoceptor agonists do not affect plasma selenium or glutathione peroxidase activity in patients with asthma.
    Burgess CD; Bremner P; Thomson CD; Crane J; Siebers RW; Beasley R
    Int J Clin Pharmacol Ther; 1994 Jun; 32(6):290-2. PubMed ID: 7921529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salmeterol post-marketing surveillance: ethical issues.
    Drug Ther Bull; 1991 Sep; 29(19):75-6. PubMed ID: 1687938
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparison of inhaled fenoterol and albuterol in asthma.
    König P; Hordvik NL; Sunderrajan EV
    Ann Allergy; 1985 Nov; 55(5):691-3. PubMed ID: 4061978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SCH 1000 in psychogenic asthma.
    Rebuck AS; Marcus HI
    Scand J Respir Dis Suppl; 1979; 103():186-91. PubMed ID: 155297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Misleading data analyses in salmeterol (SMART) study.
    Lurie P; Wolfe SM
    Lancet; 2005 Oct; 366(9493):1261-2; discussion 1262. PubMed ID: 16214589
    [No Abstract]   [Full Text] [Related]  

  • 28. Stopping long-acting beta-2 agonists.
    Med Lett Drugs Ther; 2010 Mar; 52(1334):21. PubMed ID: 20336032
    [No Abstract]   [Full Text] [Related]  

  • 29. Beta2 agonists and heart failure.
    Lindmark B; Ottosson A
    Lancet; 1998 Nov; 352(9141):1709-10. PubMed ID: 9853469
    [No Abstract]   [Full Text] [Related]  

  • 30. [The experience of using Ditec in bronchial asthma].
    Iakovlev VN; Nechaev DF; Mironov MB; Semenova TA
    Voen Med Zh; 1992 Jul; (7):34-5. PubMed ID: 1455774
    [No Abstract]   [Full Text] [Related]  

  • 31. Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma.
    Nelson HS; Berkowitz RB; Tinkelman DA; Emmett AH; Rickard KA; Yancey SW
    Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1556-61. PubMed ID: 10228126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Excess mortality in patients with asthma on long-acting beta2-agonists.
    Hasford J; Virchow JC
    Eur Respir J; 2006 Nov; 28(5):900-2. PubMed ID: 17074917
    [No Abstract]   [Full Text] [Related]  

  • 33. (R)-albuterol for asthma: pro [a.k.a. (S)-albuterol for asthma: con].
    Ameredes BT; Calhoun WJ
    Am J Respir Crit Care Med; 2006 Nov; 174(9):965-9; discussion 972-4. PubMed ID: 17060667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-acting beta 2-agonists and their role in asthma management.
    Galant SP
    West J Med; 1995 Oct; 163(4):372. PubMed ID: 7483600
    [No Abstract]   [Full Text] [Related]  

  • 35. Safety of salmeterol in the maintenance treatment of asthma.
    Nathan RA; Seltzer JM; Kemp JP; Chervinsky P; Alexander WJ; Liddle R; Mills R
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):243-8. PubMed ID: 7552926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-acting beta 2-adrenoceptor agonists: a new perspective in the treatment of asthma.
    Löfdahl CG; Chung KF
    Eur Respir J; 1991 Feb; 4(2):218-26. PubMed ID: 1675178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is salmeterol safe in asthma?
    Subramanian S; Kumaravel A
    Aust Fam Physician; 2006 Dec; 35(12):936. PubMed ID: 17201021
    [No Abstract]   [Full Text] [Related]  

  • 38. Labeling changes for asthma drug salmeterol.
    FDA Consum; 2003; 37(6):6. PubMed ID: 14983813
    [No Abstract]   [Full Text] [Related]  

  • 39. The use of beta-agonists and the risk of death and near death from asthma.
    Spitzer WO; Suissa S; Ernst P; Horwitz RI; Habbick B; Cockcroft D; Boivin JF; McNutt M; Buist AS; Rebuck AS
    N Engl J Med; 1992 Feb; 326(8):501-6. PubMed ID: 1346340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comments of the German Airway League and the German Respiratory Society to the US Food and Drug Administration (FDA)'s announcement from February 18th 2010 on the use of long acting beta-2 agonists in treatment of asthma].
    Kardos P; Berdel D; Buhl R; Criée CP; Freihorst J; Gillissen A; Karg O; Pfeifer M; Magnussen H; Rabe KF; Teschler H; Vogelmeier C; Welte T; Wettengel R; Worth H
    Pneumologie; 2010 Jun; 64(6):333-5. PubMed ID: 20533125
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.